GRAL Stock Analysis: Buy, Sell, or Hold?
GRAL - GRAIL, Inc. Common Stock
$54.27
0.67 (1.25%)
ā²
5d:
+4.05%
30d:
+0.43%
90d:
-36.59%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
GRAL is down 8.2% this week, but smart money is accumulating calls. Top strike: $50 2026-04-17 with 1,559 OI. Call ratio: 78% View Scanner →
Strength: 6.9/10
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
š” BUY OPPORTUNITY: GRAL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
š” BUY OPPORTUNITY: GRAL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $54.27, which is considered extended relative to its 30-day fair value range of $46.30 to $53.30.
Technical Outlook: Technically, GRAL is in a strong downtrend. The price is approaching resistance at $55.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GRAL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (12th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $72.40 (+35.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GRAL is in a strong downtrend. The price is approaching resistance at $55.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: GRAL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (12th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $72.40 (+35.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$46.30 -
$53.30
Company Quality Score
52/100
(HOLD)
Options IV Signal
12th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 12th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.1% below Wall St target ($72.40)
Fair Price Analysis
30-Day Fair Range
$46.30 -
$53.30
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
Ā±$5.97
(11.0%)
Support & Resistance Levels
Support Level
$45.79
Resistance Level
$55.36
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.92
Wall Street Target
$72.40
(+35.1%)
Revenue Growth (YoY)
14.0%
Profit Margin
-277.5%
Share & Embed Analysis
Last updated: April 02, 2026 11:04 AM ET
Data refreshes hourly during market hours. Next update: 12:04 PM
Data refreshes hourly during market hours. Next update: 12:04 PM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua J Ofman
SELL
2937 shares
2026-03-09
Robert P Ragusa
SELL
7461 shares
2026-03-09
Aaron Freidin
SELL
2492 shares
2026-03-09
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientificā¦ |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 66 BUY |
|
EXAS
EXACT Sciences Corporatiā¦ |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 66 BUY |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
